{
    "nctId": "NCT02745704",
    "officialTitle": "The Optimizing Treatment of PegIFN Alfa in HBeAg-negative Chronic Hepatitis B Patients With Low Level HBsAg",
    "inclusionCriteria": "1. CHB patients who had received NAs for more than 12 months.\n2. Hepatitis B e antigen (HBeAg)-negative and anti-HBeAg positive.\n3. Hepatitis B surface antigen (HBsAg) positive and \\<1500 IU/mL.\n4. Hepatitis B virus DNA not detectable(Roche Cobas).\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "1. Patients with liver cirrhosis, Hepatocellular Carcinoma or other malignancies.\n2. Patients with other factors causing liver diseases.\n3. Pregnant and lactating women.\n4. Patients with concomitant HIV infection or congenital immune deficiency diseases.\n5. Patients with diabetes, autoimmune diseases.\n6. Patients with important organ dysfunctions.\n7. Patients with serious complications (e.g., infection, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding.)\n8. Patients who receive antineoplastic or immunomodulatory therapy in the past 12 months.\n9. Patients who can't come back to clinic for follow-up on schedule."
}